Company / Working Capital
ACCENDRA HEALTH INC/VA/ Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
-$399.2M
FY2025
5-year range
-$399.2M / $977.8M
FY2021-FY2025
Trend
-336.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital changed -336% YoY in FY2025, a notable deviation from the 9-year average annual change of -49%.
Based on SEC 10-K filings.
-$399M in FY2025.
Declined from $211M to -$399M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- ACCENDRA HEALTH INC/VA/'s working capital has declined for 4 consecutive years.
- In FY2025, working capital decreased 336.3% year-over-year.
- Peak working capital was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.60 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$399.2M | -336.3% |
| FY2024 | $169.0M | -19.9% |
| FY2023 | $210.9M | -71.1% |
| FY2022 | $728.7M | -25.5% |
| FY2021 | $977.8M | +23.7% |
| FY2020 | $790.1M | -20.3% |
| FY2019 | $991.1M | -7.1% |
| FY2018 | $1.1B | +22.3% |
| FY2017 | $872.2M | -6.0% |
| FY2016 | $927.4M | +1.8% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026